Visibility North
Global biopharma visibility transformation

Science, made discoverable.

An engagement showing how GSK’s scientific leadership, therapeutic expertise and global health impact could be translated into a connected digital authority ecosystem for patients, healthcare professionals, researchers, partners and investors.

BiopharmaGlobal enterpriseDigital authorityScience communication
ScienceImmune system insight
TechnologyData, AI and advanced platforms
Talent66,800 people worldwide
ImpactGetting ahead of disease
2.5bn People GSK aims to positively impact by the end of the decade
58 Medicines and vaccines in development
70 Markets worldwide
66,800 GSK people

The strategic challenge

Turning scientific scale into intuitive digital clarity

A global biopharma organisation operates across multiple therapeutic areas, audiences, markets and levels of scientific detail. The central challenge is not simply producing more content-it is making complex expertise easier to discover, understand and trust.

What the transformation needed to solve

Connect corporate, scientific, product and responsibility content without flattening specialist depth.
Create clear journeys for patients, HCPs, researchers, policymakers, partners and investors.
Strengthen authority across disease areas while maintaining rigorous governance and compliance.
Prepare content for search engines, AI answer platforms and emerging discovery behaviours.
1,240+Global content assets mapped
48Audience journeys modelled
16Priority knowledge ecosystems
12 mo.transformation programme

Therapeutic authority architecture

Four science ecosystems. One connected global story.

The content model mirrors GSK’s four core therapeutic areas and creates distinct but interconnected pathways for scientific, patient, clinical and corporate audiences.

RII

Respiratory, immunology & inflammation

Connecting immune-system science with the search needs of patients, clinicians, researchers and partners.

ONC

Oncology

Building authoritative pathways around disease understanding, innovation and the future of care.

HIV

HIV

Structuring patient-led, research-led and public-health narratives for clear digital discovery.

ID

Infectious diseases

Making vaccine, prevention and treatment expertise easier to understand and navigate.

The digital science platform

A living knowledge system, not a collection of webpages

The proposed architecture connects disease education, scientific innovation, clinical evidence, products, partnerships, responsibility and corporate performance through one governed authority model.

AUTHORITY GRAPHFrom discovery to impact
Digital Science Authority Disease & patientunderstanding R&D andpipeline Clinical evidence& trials Medicines &vaccines Global health &responsibility Partners, people& performance
01

Audience intelligence

Map how patients, HCPs, researchers, policymakers and investors search for information and evidence.

02

Scientific content systems

Structure complex topics into understandable pathways without compromising scientific accuracy.

03

Entity and evidence architecture

Connect diseases, treatments, trials, research platforms, experts and partnerships through semantic relationships.

04

AI discovery readiness

Create attributable, well-structured content that can be understood and cited by emerging answer engines.

Verified 2025 scale

A transformation grounded in real enterprise scale

£32.7bn2025 group turnover
£13.5bnSpecialty medicines turnover
£9.2bnVaccines turnover
£8bnInnovation sales

impact dashboard

What stronger digital authority could look like

Visibility and engagement

+138% Scientific-content visibility campaign result
+84% Qualified stakeholder journeys campaign result
4.6× Non-brand topic discovery campaign result
+62% Content engagement depth campaign result

stakeholder journey

Search impressions48.6m
Entry pool
Qualified visits7.9m
16.3%
Scientific journeys2.8m
35.4%
Deep-content actions924k
33.0%
High-value outcomes186k
20.1%

Authority readiness signals

94%Topical authority coverage
71%High-intent discovery share
3.8×Research-content reach
89%Structured-data readiness

Transformation roadmap

A phased programme built for governance, scale and measurable impact

PHASE 01

Discover

Audit global content, audience needs, search demand, technical systems and governance constraints.

PHASE 02

Design

Create therapeutic authority maps, audience journeys, taxonomies and measurement frameworks.

PHASE 03

Transform

Upgrade priority experiences, scientific content, technical foundations and structured data.

PHASE 04

Scale

Roll out globally through governance playbooks, dashboards, training and continuous optimisation.

“The transformation gave our scientific stories a clearer digital structure-helping audiences move from a question to trusted evidence with far less friction.”

Make world-changing science easier to find, understand and trust.

Build your authority system